全文获取类型
收费全文 | 334篇 |
免费 | 22篇 |
专业分类
妇产科学 | 1篇 |
基础医学 | 10篇 |
临床医学 | 6篇 |
内科学 | 30篇 |
神经病学 | 3篇 |
特种医学 | 1篇 |
外科学 | 20篇 |
综合类 | 2篇 |
预防医学 | 97篇 |
药学 | 6篇 |
肿瘤学 | 180篇 |
出版年
2023年 | 4篇 |
2022年 | 2篇 |
2021年 | 5篇 |
2020年 | 12篇 |
2019年 | 8篇 |
2018年 | 16篇 |
2017年 | 10篇 |
2016年 | 5篇 |
2015年 | 6篇 |
2014年 | 5篇 |
2013年 | 9篇 |
2012年 | 16篇 |
2011年 | 21篇 |
2010年 | 4篇 |
2009年 | 7篇 |
2008年 | 14篇 |
2007年 | 22篇 |
2006年 | 26篇 |
2005年 | 20篇 |
2004年 | 12篇 |
2003年 | 15篇 |
2002年 | 12篇 |
2001年 | 18篇 |
2000年 | 11篇 |
1999年 | 9篇 |
1998年 | 4篇 |
1997年 | 1篇 |
1996年 | 2篇 |
1995年 | 2篇 |
1994年 | 2篇 |
1992年 | 3篇 |
1991年 | 12篇 |
1990年 | 2篇 |
1989年 | 4篇 |
1988年 | 3篇 |
1987年 | 6篇 |
1986年 | 7篇 |
1985年 | 4篇 |
1984年 | 2篇 |
1980年 | 1篇 |
1978年 | 2篇 |
1976年 | 4篇 |
1974年 | 1篇 |
1973年 | 1篇 |
1969年 | 1篇 |
1968年 | 2篇 |
1966年 | 1篇 |
排序方式: 共有356条查询结果,搜索用时 46 毫秒
71.
Chuang SC Gallo V Michaud D Overvad K Tjønneland A Clavel-Chapelon F Romieu I Straif K Palli D Pala V Tumino R Sacerdote C Panico S Peeters PH Lund E Gram IT Manjer J Borgquist S Riboli E Vineis P 《Cancer causes & control : CCC》2011,22(3):487-494
The association between childhood environmental tobacco smoke (ETS) exposure and adult cancer risk is controversial; we examined this relationship in never smokers within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Over an average of 10 years, 8,372 cases of cancer were diagnosed in 112,430 never smokers in EPIC. Childhood ETS was self-reported by participants at baseline, along with other lifestyle factors. Hazard ratios (HR) for ETS exposure in childhood and their 95% confidence intervals (CI) were estimated by Cox proportional hazards models stratified by age, sex, and study center and adjusted for education, alcohol drinking, body mass index, physical activity, non-alcoholic energy intake, fruit and vegetable intake, and adulthood ETS exposure. Models were further adjusted for reproductive factors for female cancers, for meat intake for digestive system cancers, and for diabetes status for pancreatic cancer. No association was observed between childhood ETS exposure and overall cancer risks (HR = 0.97, 95% CI = 0.92-1.02), and for selected sites. The only exception was pancreatic cancer, as previously reported by Vrieling et al., among those who had been exposed daily in childhood (overall HR = 2.09, 95% CI = 1.14-3.84). In conclusion, childhood ETS exposure might not be a major risk factor for common cancers in adulthood. 相似文献
72.
Munafò MR Timofeeva MN Morris RW Prieto-Merino D Sattar N Brennan P Johnstone EC Relton C Johnson PC Walther D Whincup PH Casas JP Uhl GR Vineis P Padmanabhan S Jefferis BJ Amuzu A Riboli E Upton MN Aveyard P Ebrahim S Hingorani AD Watt G Palmer TM Timpson NJ;EPIC Study Group Davey Smith G 《Journal of the National Cancer Institute》2012,104(10):740-748
73.
Brennan K Garcia-Closas M Orr N Fletcher O Jones M Ashworth A Swerdlow A Thorne H;KConFab Investigators Riboli E Vineis P Dorronsoro M Clavel-Chapelon F Panico S Onland-Moret NC Trichopoulos D Kaaks R Khaw KT Brown R Flanagan JM 《Cancer research》2012,72(9):2304-2313
Few studies have evaluated the association between DNA methylation in white blood cells (WBC) and the risk of breast cancer. The evaluation of WBC DNA methylation as a biomarker of cancer risk is of particular importance as peripheral blood is often available in prospective cohorts and easier to obtain than tumor or normal tissues. Here, we used prediagnostic blood samples from three studies to analyze WBC DNA methylation of two ATM intragenic loci (ATMmvp2a and ATMmvp2b) and genome-wide DNA methylation in long interspersed nuclear element-1 (LINE1) repetitive elements. Samples were from a case-control study derived from a cohort of high-risk breast cancer families (KConFab) and nested case-control studies in two prospective cohorts: Breakthrough Generations Study (BGS) and European Prospective Investigation into Cancer and Nutrition (EPIC). Bisulfite pyrosequencing was used to quantify methylation from 640 incident cases of invasive breast cancer and 741 controls. Quintile analyses for ATMmvp2a showed an increased risk of breast cancer limited to women in the highest quintile [OR, 1.89; 95% confidence interval (CI), 1.36-2.64; P = 1.64 × 10(-4)]. We found no significant differences in estimates across studies or in analyses stratified by family history or menopausal status. However, a more consistent association was observed in younger than in older women and individually significant in KConFab and BGS, but not EPIC. We observed no differences in LINE1 or ATMmvp2b methylation between cases and controls. Together, our findings indicate that WBC DNA methylation levels at ATM could be a marker of breast cancer risk and further support the pursuit of epigenome-wide association studies of peripheral blood DNA methylation. 相似文献
74.
Haiman CA Dossus L Setiawan VW Stram DO Dunning AM Thomas G Thun MJ Albanes D Altshuler D Ardanaz E Boeing H Buring J Burtt N Calle EE Chanock S Clavel-Chapelon F Colditz GA Cox DG Feigelson HS Hankinson SE Hayes RB Henderson BE Hirschhorn JN Hoover R Hunter DJ Kaaks R Kolonel LN Le Marchand L Lenner P Lund E Panico S Peeters PH Pike MC Riboli E Tjonneland A Travis R Trichopoulos D Wacholder S Ziegler RG 《Cancer research》2007,67(5):1893-1897
The CYP19A1 gene encodes the enzyme aromatase, which is responsible for the final step in the biosynthesis of estrogens. In this study, we used a systematic two-step approach that included gene resequencing and a haplotype-based analysis to comprehensively survey common genetic variation across the CYP19A1 locus in relation to circulating postmenopausal steroid hormone levels and breast cancer risk. This study was conducted among 5,356 invasive breast cancer cases and 7,129 controls comprised primarily of White women of European descent drawn from five large prospective cohorts within the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. A high-density single-nucleotide polymorphism (SNP) map of 103 common SNPs (> or =5% frequency) was used to identify the linkage disequilibrium and haplotype patterns across the CYP19A1 locus, and 19 haplotype-tagging SNPs were selected to provide high predictability of the common haplotype patterns. We found haplotype-tagging SNPs and common haplotypes spanning the coding and proximal 5' region of CYP19A1 to be significantly associated with a 10% to 20% increase in endogenous estrogen levels in postmenopausal women [effect per copy of the two-SNP haplotype rs749292-rs727479 (A-A) versus noncarriers; P = 4.4 x 10(-15)]. No significant associations were observed, however, with these SNPs or common haplotypes and breast cancer risk. Thus, although genetic variation in CYP19A1 produces measurable differences in estrogen levels among postmenopausal women, the magnitude of the change was insufficient to contribute detectably to breast cancer. 相似文献
75.
Jenab M Riboli E Cleveland RJ Norat T Rinaldi S Nieters A Biessy C Tjønneland A Olsen A Overvad K Grønbaek H Clavel-Chapelon F Boutron-Ruault MC Linseisen J Boeing H Pischon T Trichopoulos D Oikonomou E Trichopoulou A Panico S Vineis P Berrino F Tumino R Masala G Peters PH van Gils CH Bueno-de-Mesquita HB Ocké MC Lund E Mendez MA Tormo MJ Barricarte A Martínez-García C Dorronsoro M Quirós JR Hallmans G Palmqvist R Berglund G Manjer J Key T Allen NE Bingham S Khaw KT Cust A Kaaks R 《International journal of cancer. Journal international du cancer》2007,121(2):368-376
Western style diets and lifestyles are associated with increasing rates of obesity, diabetes and insulin resistance. Higher circulating insulin levels may modulate cell proliferation and apoptosis either directly or indirectly by increasing the bioactivity of IGF-I and decreasing the bioactivity of some of its binding proteins. The objective of this study was to determine the association of increasing levels of serum C-peptide, a biomarker of pancreatic insulin secretion, and IGF binding proteins (IGFBP) -1 and -2 with colorectal cancer risk in a case-control study nested within the European Prospective Investigation into Cancer and Nutrition (EPIC), a large cohort involving 10 Western European countries. A total of 1,078 colorectal cancer cases were matched (age, date of blood donation, fasting status, gender, study center) to an equal number of control subjects. Relative cancer risks were estimated using conditional logistic regression models. Serum C-peptide concentration was positively associated with an increased colorectal cancer risk for the highest versus the lowest quintile (OR=1.56, 95% CI=1.16-2.09, p(trend)<0.01), which was slightly attenuated after adjustment for BMI and physical activity (OR=1.37, 95% CI=1.00-1.88, p(trend)=0.10). When stratified by anatomical site, the cancer risk was stronger in the colon (OR=1.67, 95% CI=1.14-2.46, p(trend)<0.01) than in the rectum (OR=1.42, 95% CI=0.90-2.25, p(trend)=0.35). The cancer risk estimates were not heterogeneous by gender or fasting status. No clear colorectal cancer risk associations were observed for IGFBP-1 or -2. This large prospective study confirms that hyperinsulinemia, as determined by C-peptide levels, is associated with an increased colorectal cancer risk. 相似文献
76.
Travis RC Key TJ Allen NE Appleby PN Roddam AW Rinaldi S Egevad L Gann PH Rohrmann S Linseisen J Pischon T Boeing H Johnsen NF Tjønneland A Overvad K Kiemeney L Bueno-de-Mesquita HB Bingham S Khaw KT Tumino R Sieri S Vineis P Palli D Quirós JR Ardanaz E Chirlaque MD Larrañaga N Gonzalez C Sanchez MJ Trichopoulou A Bikou C Trichopoulos D Stattin P Jenab M Ferrari P Slimani N Riboli E Kaaks R 《International journal of cancer. Journal international du cancer》2007,121(6):1331-1338
We examined the hypothesis that serum concentrations of circulating androgens and sex hormone binding globulin (SHBG) are associated with risk for prostate cancer in a case-control study nested in the European Prospective Investigation into Cancer and Nutrition (EPIC). Concentrations of androstenedione, testosterone, androstanediol glucuronide and SHBG were measured in serum samples for 643 prostate cancer cases and 643 matched control participants, and concentrations of free testosterone were calculated. Conditional logistic regression models were used to calculate odds ratios for risk of prostate cancer in relation to the serum concentration of each hormone. After adjustment for potential confounders, there was no significant association with overall risk for prostate cancer for serum total or free testosterone concentrations (highest versus the lowest thirds: OR, 1.02; 95% CI, 0.73-1.41 and OR, 1.07, 95% CI, 0.74-1.55, respectively) or for other androgens or SHBG. Subgroup analyses showed significant heterogeneity for androstenedione by cancer stage, with a significant inverse association of androstenedione concentration and risk for advanced prostate cancer. There were also weak positive associations between free testosterone concentration and risk for total prostate cancer among younger men and risk for high-grade disease. In summary, in this large nested case-control study, concentrations of circulating androgens or SHBG were not strongly associated with risk for total prostate cancer. However, our findings are compatible with a positive association of free testosterone with risk in younger men and possible heterogeneity in the association with androstenedione concentration by stage of disease; these findings warrant further investigation. 相似文献
77.
Manuguerra M Matullo G Veglia F Autrup H Dunning AM Garte S Gormally E Malaveille C Guarrera S Polidoro S Saletta F Peluso M Airoldi L Overvad K Raaschou-Nielsen O Clavel-Chapelon F Linseisen J Boeing H Trichopoulos D Kalandidi A Palli D Krogh V Tumino R Panico S Bueno-De-Mesquita HB Peeters PH Lund E Pera G Martinez C Amiano P Barricarte A Tormo MJ Quiros JR Berglund G Janzon L Jarvholm B Day NE Allen NE Saracci R Kaaks R Ferrari P Riboli E Vineis P 《Carcinogenesis》2007,28(2):414-422
It is becoming increasingly evident that single-locus effects cannot explain complex multifactorial human diseases like cancer. We applied the multi-factor dimensionality reduction (MDR) method to a large cohort study on gene-environment and gene-gene interactions. The study (case-control nested in the EPIC cohort) was established to investigate molecular changes and genetic susceptibility in relation to air pollution and environmental tobacco smoke (ETS) in non-smokers. We have analyzed 757 controls and 409 cases with bladder cancer (n=124), lung cancer (n=116) and myeloid leukemia (n=169). Thirty-six gene variants (DNA repair and metabolic genes) and three environmental exposure variables (measures of air pollution and ETS at home and at work) were analyzed. Interactions were assessed by prediction error percentage and cross-validation consistency (CVC) frequency. For lung cancer, the best model was given by a significant gene-environment association between the base excision repair (BER) XRCC1-Arg399Gln polymorphism, the double-strand break repair (DSBR) BRCA2-Asn372His polymorphism and the exposure variable 'distance from heavy traffic road', an indirect and robust indicator of air pollution (mean prediction error of 26%, P<0.001, mean CVC of 6.60, P=0.02). For bladder cancer, we found a significant 4-loci association between the BER APE1-Asp148Glu polymorphism, the DSBR RAD52-3'-untranslated region (3'-UTR) polymorphism and the metabolic gene polymorphisms COMT-Val158Met and MTHFR-677C>T (mean prediction error of 22%, P<0.001, mean CVC consistency of 7.40, P<0.037). For leukemia, a 3-loci model including RAD52-2259C>T, MnSOD-Ala9Val and CYP1A1-Ile462Val had a minimum prediction error of 31% (P<0.001) and a maximum CVC of 4.40 (P=0.086). The MDR method seems promising, because it provides a limited number of statistically stable interactions; however, the biological interpretation remains to be understood. 相似文献
78.
Peeters PH Lukanova A Allen N Berrino F Key T Dossus L Rinaldi S van Gils CH Bueno-de-Mesquita HB Boeing H Schulz M Chang-Claude J Linseisen J Panico S Sacerdote C Palli D Tumino R Trichopoulou A Trichopolos D Bamia C Larranaga N Ardanaz E Pera G Quirós JR Martínez-García C Navarro C Bingham SA Khaw KT Clavel F Tjonneland A Olsen A Overvad K Tetsche MS Lund E Lundin E Berglund G Riboli E Kaaks R 《Endocrine-related cancer》2007,14(1):81-90
We set out to study the relationship between circulating levels of IGF-I and its major binding protein (IGFBP-3) in relation to ovarian cancer risk. We conducted a case-control study nested within the European Prospective Investigation into Cancer and Nutrition. Levels of IGF-I and IGFBP-3 were measured in prediagnostic serum samples of 214 women who subsequently developed ovarian cancer, and 388 matched control subjects. Conditional logistic regression models were used to estimate relative risks of ovarian cancer by tertiles of IGF-I and IGFBP-3 levels. For all women, there was no association between the circulating IGF-I or IGFBP-3 levels and the risk of ovarian cancer. However, among women diagnosed with ovarian cancer aged 55 or younger, the relative risk was higher in the middle or top tertiles of serum IGF-I, when compared with women in the lowest tertile (odds ratios (OR) = 1.8 (95%CI 0.7-4.3) and OR = 2.4 (95%CI 0.9-6.4); P(trend) = 0.08) respectively. These results were adjusted for body mass index, previous hormone use, fertility problems, and parity. Restricting the analysis to women who were premenopausal at blood donation, relative risks for ovarian cancer diagnosed before age 55 were higher (OR = 5.1 (95%CI 1.5-18.2) and OR = 5.6 (95%CI 1.5-20.8) respectively, for second and third tertiles; P(trend) = 0.02). Adjustment for serum IGFBP-3 levels only slightly attenuated relative risk estimates. Relations between IGFBP-3 and ovarian cancer before age 55 were in the same direction as for IGF-I, but less strong and statistically not significant. In women aged over 55, there was no association between serum IGF-I or IGFBP-3 and ovarian cancer risk. Our results suggest that the circulating levels of IGF-I may play a potentially important role in the development of ovarian cancer in women of a pre- or perimenopausal age. 相似文献
79.
Carneiro F Moutinho C Pera G Caldas C Fenger C Offerhaus J Save V Stenling R Nesi G Mahlke U Bläker H Torrado J Roukos DH Sabourin JC Boeing H Palli D Bueno-de-Mesquita HB Overvad K Bingham S Clavel-Chapelon F Lund E Trichopoulou A Manjer J Riboli E Gonzalez CA 《Scandinavian journal of gastroenterology》2007,42(5):618-627
OBJECTIVE: Cardia, non-cardia and intestinal and diffuse subtypes of gastric cancer may have different trends and etiological factors. However, the available information is not always collected in population cancer registries, and heterogeneous criteria have been applied for the histopathological classification of tumors. We describe the pathological features of incident gastric and esophageal cancers identified within the European Prospective Investigation into Cancer and Nutrition (EPIC). MATERIAL AND METHODS: In an investigation on gastric and esophageal cancer (EUR-GAST) in the EPIC project, a validation study of diagnoses reported by EPIC centers was conducted by a European panel of pathologists. Original pathology reports, stained slides of tumors and the respective paraffin blocks were requested from the centers. RESULTS: The whole series encompassed 467 cancer cases (gastric and esophageal cancers). Material was available for histopathological validation in 263 cases (56%); in the remaining cases, information was retrieved from the original reports (n=110; 24%) or codes provided by the EPIC centers (n=94; 20%). Among cases submitted to histopathological validation reported originally as unknown histotype or unknown site, a specific diagnosis was made in 95% and 74% of the cases, respectively. In cases for which only the original reports were available, the respective percentages were 46% and 67%. Gastric adenocarcinomas were classified according to site (cardia (29.4%), non-cardia (48.2%) and unknown (22.4%)) and histological type (intestinal (33.4%), diffuse (33.7%) and mixed, unclassified or unknown (32.9%)). Frequency of cardia was higher in Northern countries (35%) than in Mediterranean countries (18%). CONCLUSIONS: In addition to providing epidemiological data within the EPIC cohort on gastric and esophageal adenocarcinomas, the results reported here confirm the relevance of a validation study, notably for multicenter studies. 相似文献
80.